Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ARDT
ARDT logo

ARDT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
9.660
Open
9.240
VWAP
9.26
Vol
342.56K
Mkt Cap
1.33B
Low
9.050
Amount
3.17M
EV/EBITDA(TTM)
3.99
Total Shares
143.35M
EV
2.26B
EV/OCF(TTM)
5.19
P/S(TTM)
0.21
Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.
Show More

Events Timeline

(ET)
2026-06-03
09:40:00
Morgan Stanley Maintains Equal Weight Rating on Ardent Health with $12 Price Target
select
2026-06-02 (ET)
2026-06-02
16:20:00
Ardent Health Appoints Dave Caspers as CEO
select
2026-05-14 (ET)
2026-05-14
08:20:00
Ardent Health Partners with Fujifilm Healthcare to Implement Imaging Solutions
select
2026-05-05 (ET)
2026-05-05
16:40:00
Sees FY26 Revenue of $6.4B-$6.7B
select
2026-05-05
16:40:00
Ardent Health Reports Q1 Revenue of $1.6B
select

News

Fool
5.0
06-12Fool
Ardent Health Director Increases Stock Holdings
  • Insider Buying Signal: On June 5, 2026, Ardent Health Director Robert DeMichiei purchased 11,260 shares at $8.73 each, totaling approximately $98,000, which increased his direct holdings by 46%, indicating confidence in the company's future.
  • Market Performance Analysis: DeMichiei's purchase comes amid a 27.51% decline in share price over the past year, suggesting his view on the stock's potential diverges from market trends, possibly indicating future price rebound potential.
  • Executive Buying Trend: On the same day, Ardent's CFO also bought 10,000 shares, reflecting a strong confidence among executives regarding future performance, which enhances investor optimism about the company's outlook.
  • Financial Health Overview: Ardent Health reported $6.43 billion in revenue and $134.28 million in net income over the past 12 months, and despite facing stock price pressures, its extensive network and diversified services continue to provide competitive advantages in the healthcare sector.
NASDAQ.COM
5.0
06-12NASDAQ.COM
Ardent Health Director Increases Stock Holdings
  • Share Acquisition: On June 5, 2026, Robert DeMichiei purchased 11,260 shares of Ardent Health at approximately $8.73 per share for a total transaction value of about $98,000, increasing his direct holdings by 46% to a total of 35,564 shares, indicating strong confidence in the company's future prospects.
  • First Open-Market Purchase: This transaction marks DeMichiei's first reported open-market buy of Ardent Health shares, reflecting his expectation for a rebound in the stock price, particularly in light of the significant declines experienced over the past year.
  • Insider Buying Signal: DeMichiei's purchase coincided with the Ardent CFO's acquisition of 10,000 shares on the same day, suggesting a bullish sentiment among company insiders regarding future stock price increases, which could positively influence investor sentiment.
  • Financial Performance and Market Reaction: Although Ardent Health exceeded analysts' expectations in the first quarter, the management's decision not to raise the full-year 2026 guidance was perceived as bearish; however, the insider buying activity may bolster market confidence in the company's stock.
NASDAQ.COM
5.0
06-03NASDAQ.COM
Ardent Health Appoints New CEO Amid Financial Guidance Reaffirmation
  • Executive Change: Ardent Health has appointed Dave Caspers as the new CEO, succeeding Marty Bonick, who stepped down to pursue other opportunities; Caspers joined the company in March 2025 and has been leading operational initiatives and growth priorities.
  • Financial Guidance Reaffirmation: The company reaffirmed its adjusted EBITDA guidance for 2026 at $485 million to $535 million, which is lower than the $545 million reported in 2025, indicating challenges in the current market environment.
  • Operational Program Expansion: Under Caspers' leadership, the IMPACT program will be accelerated and expanded to address observed volume softness in the second quarter, demonstrating the company's commitment to improving operational performance.
  • Stock Price Fluctuation: Ardent Health's stock has traded between $8.07 and $15.48 over the past year, closing at $9.27, though it has seen a pre-market decline of 3.56% to $8.94, reflecting market reactions to the new CEO appointment.
seekingalpha
5.0
06-02seekingalpha
Ardent Health Appoints New CEO to Drive Growth
  • Leadership Change: Ardent Health has appointed Dave Caspers as CEO, effective immediately, succeeding Marty Bonick, with the leadership transition aimed at enhancing operational efficiency and execution to support the company's next growth phase.
  • Financial Guidance Reaffirmed: The company reaffirmed its full-year 2026 adjusted EBITDA guidance of $485 million to $535 million, reflecting confidence in future financial performance and providing investors with a stable return outlook.
  • Cost Savings Target: Ardent has set a $55 million IMPACT savings target while completing the rollout of 2,000 hellocare.ai rooms by year-end, aiming to enhance service efficiency and customer satisfaction through technological innovation.
  • Executive Appointment Impact: Caspers' appointment as former COO not only strengthens the company's governance structure but also provides Ardent Health with enhanced strategic execution capabilities in the competitive healthcare sector, expected to drive further market development.
Newsfilter
5.0
06-02Newsfilter
Ardent Health Appoints New CEO to Drive Growth
  • Leadership Transition: Ardent Health has appointed Dave Caspers as the new CEO, succeeding Marty Bonick, with Caspers bringing extensive operational experience to sharpen focus on operational efficiency and execution, thereby positioning the company for sustained growth in a dynamic environment.
  • Financial Guidance Reaffirmed: The company reaffirms its full-year 2026 Adjusted EBITDA guidance of $485 to $535 million, despite observing volume softness in the second quarter, indicating decisive actions taken to navigate market challenges.
  • IMPACT Program Expansion: Under Caspers' leadership, the IMPACT program will be accelerated and expanded to improve margins and operational performance, further driving the transformation of healthcare services in response to industry changes and demands.
  • Vision Reinforcement: Caspers emphasized a continued commitment to delivering high-quality healthcare, ensuring Ardent Health remains competitive in the growing healthcare market, particularly in mid-sized urban communities across the U.S.
NASDAQ.COM
2.0
05-06NASDAQ.COM
Ardent Health (ARDT) Q1 2026 Earnings Transcript
Wall Street analysts forecast ARDT stock price to rise
13 Analyst Rating
Wall Street analysts forecast ARDT stock price to rise
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 0.000
sliders
Low
10.00
Averages
13.73
High
17.00
Current: 0.000
sliders
Low
10.00
Averages
13.73
High
17.00
UBS
Buy
maintain
$13
AI Analysis
2026-05-07
Reason
UBS
Price Target
$13
AI Analysis
2026-05-07
maintain
Buy
Reason
UBS raised the firm's price target on Ardent Health to $13.50 from $13 and keeps a Buy rating on the shares.
Guggenheim
Buy
to
Buy
downgrade
$15 -> $13
2026-04-13
Reason
Guggenheim
Price Target
$15 -> $13
2026-04-13
downgrade
Buy
to
Buy
Reason
Guggenheim lowered the firm's price target on Ardent Health to $13 from $15 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ARDT
Unlock Now

Valuation Metrics

The current forward P/E ratio for Ardent Health Inc (ARDT.N) is 8.72, compared to its 5-year average forward P/E of 8.24. For a more detailed relative valuation and DCF analysis to assess Ardent Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
8.24
Current PE
8.72
Overvalued PE
9.94
Undervalued PE
6.55

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
6.93
Current EV/EBITDA
5.97
Overvalued EV/EBITDA
8.52
Undervalued EV/EBITDA
5.33

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.30
Current PS
0.20
Overvalued PS
0.38
Undervalued PS
0.21

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

Market Movers
Intellectia · 54 candidates
Market Cap: >= 1000.00MVolume: >= -100Price Change Pct: $-100.00 - $100.00Relative Vol: >= 2Monthly Average Dollar Volume: >= -100
Ticker
Name
Market Cap$
top bottom
TWLO logo
TWLO
Twilio Inc
27.83B
BAND logo
BAND
Bandwidth Inc
1.44B
SOUN logo
SOUN
SoundHound AI Inc
4.07B
NVT logo
NVT
nVent Electric PLC
25.70B
VEEV logo
VEEV
Veeva Systems Inc
28.03B
BTSG logo
BTSG
Brightspring Health Services Inc
10.16B
price less than $10
Intellectia · 23 candidates
Market Cap: >= 500.00MPrice: <= $10.00Weekly Average Turnover: >= 1,000,000Pe Ttm: 0 - 25Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
ABEV logo
ABEV
Ambev SA
41.38B
BBD logo
BBD
Banco Bradesco SA
39.45B
SUZ logo
SUZ
Suzano SA
12.05B
YMM logo
YMM
Full Truck Alliance Co Ltd
10.30B
INTR logo
INTR
Inter & Co Inc
3.88B
FUBO logo
FUBO
FuboTV Inc
3.33B
quality stocks below $10
Intellectia · 17 candidates
Market Cap: >= 1000.00MPrice: <= $10.00Weekly Average Turnover: >= 1,000,000Pe Ttm: 5 - 25Return On Equity: >= 10.0%
Ticker
Name
Market Cap$
top bottom
ITUB logo
ITUB
Itau Unibanco Holding SA
86.67B
ABEV logo
ABEV
Ambev SA
41.38B
BBD logo
BBD
Banco Bradesco SA
39.45B
WIT logo
WIT
Wipro Ltd
27.24B
NMR logo
NMR
Nomura Holdings Inc
26.35B
VG logo
VG
Venture Global Inc
22.16B

Whales Holding ARDT

C
Castleknight Management LP
Holding
ARDT
+52.52%
3M Return
G
GoldenTree Asset Management LP
Holding
ARDT
+7.09%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Ardent Health Inc (ARDT) stock price today?

The current price of ARDT is 9.08 USD — it has decreased -1.94

What is Ardent Health Inc (ARDT)'s business?

Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.

What is the price predicton of ARDT Stock?

Wall Street analysts forecast ARDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARDT is13.73 USD with a low forecast of 10.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Ardent Health Inc (ARDT)'s revenue for the last quarter?

Ardent Health Inc revenue for the last quarter amounts to 1.60B USD, increased 6.99

What is Ardent Health Inc (ARDT)'s earnings per share (EPS) for the last quarter?

Ardent Health Inc. EPS for the last quarter amounts to 0.28 USD, decreased -3.45

How many employees does Ardent Health Inc (ARDT). have?

Ardent Health Inc (ARDT) has 19500 emplpoyees as of June 17 2026.

What is Ardent Health Inc (ARDT) market cap?

Today ARDT has the market capitalization of 1.33B USD.